SOP for Conducting Stability Testing for Modified-Release Formulations in Compliance with Regulatory Guidelines

Procedure for Stability Testing of Modified-Release Formulations

1) Purpose

The purpose of this SOP is to establish a procedure for conducting stability testing of modified-release formulations in compliance with relevant regulatory guidelines. This ensures that these formulations maintain their desired release profiles, quality, safety, and efficacy throughout their shelf life.

2) Scope

This SOP applies to all personnel involved in the stability testing of modified-release drug products, including formulation development, quality control, and regulatory affairs teams.

3) Responsibilities

Formulation Development Team: Responsible for developing modified-release formulations and selecting suitable packaging materials.
Stability Study Team: Responsible for conducting stability studies according to approved protocols.
Regulatory Affairs Team: Responsible for ensuring compliance with regulatory guidelines and preparing stability data for submission to authorities.

4) Procedure

4.1 Protocol Development

4.1.1 Develop a stability testing protocol that includes parameters specific to modified-release formulations, such as dissolution profiles, assay, and degradation products.

4.1.2

Define storage conditions (e.g., room temperature, accelerated) and testing intervals (e.g., 0, 3, 6, 12 months) based on regulatory guidelines.

4.2 Sample Preparation and Storage

4.2.1 Prepare samples in their final packaging for stability testing, ensuring uniformity in dosage form and packaging configuration.

4.2.2 Store samples under specified conditions according to the protocol, and monitor storage environments continuously.

4.3 Conducting Stability Tests

4.3.1 Perform stability tests at all required intervals, including assessments of dissolution profile, potency, and physical attributes.

4.3.2 Record all data accurately and ensure compliance with the approved protocol.

4.4 Data Analysis and Reporting

4.4.1 Analyze stability data to detect any trends, deviations, or failures that could impact product performance.

4.4.2 Prepare a comprehensive stability report for regulatory submission, including all findings and conclusions.

5) Abbreviations, if any

QA: Quality Assurance

6) Documents, if any

6.1 Stability testing protocols
6.2 Data sheets
6.3 Stability reports

7) Reference, if any

FDA Guidance for Industry: Stability Testing of Modified-Release Formulations

8) SOP Version

Version 1.0